Atuka sets a higher standard for neuroscientific expertise and rigor, providing unmatched translational drug development and chemistry services to identify and advance breakthrough neurotherapeutic candidates. We are deeply experienced in Parkinson’s disease and other movement-related disorders, as well as cognitive diseases. We also offer industry-leading rodent and non-human primate models. 

At Atuka, we simply do better science. Explore our resources to learn more. 

Recent Publications

In collaboration with researchers in Wurzburg, Germany, Atuka co-authored a paper that further characterizes the AAV-A53T-aSyn rat model of Parkinson’s disease. Atuka extensively uses this model to evaluate potential therapies. Read the full paper. 

Fact Sheets

We provide the finest rodent models and non-human primate models in the contract research industry, and we have the expertise to get the data you need to accurately assess your therapy.

View Fact Sheets

Explore our models and other services:

We provide the finest rodent models and non-human primate models in the contract research industry, and we have the expertise to get the data you need to accurately assess your therapy.

Primate Parkinson’s disease
  • AAV alpha-synuclein primate 
  • PFF alpha-synuclein primate 
  • MPTP primate 
  • Primate dyskinesia 
Rodent Parkinson’s disease
  • AAV alpha-synuclein rodent (mouse and rat) 
  • PFF alpha-synuclein rodent (mouse and rat) 
  • MPTP mouse 
  • 6-OHDA rat 
  • Rodent dyskinesia 
Primate cognition
  • cld-MPTP
  • Scopolamine
  • Aged
  • Normal
Other services
  • Primate services 
  • Chemistry 
  • Biodistribution (primate and rodent) 
  • Non-GLP toxicity (primate) 
  • Anxiety (primate)